Comments
Loading...

Eagle Pharmaceuticals

EGRXOTCEM
Logo brought to you by Benzinga Data
$0.5500
-0.05-8.33%
At close: -
$0.8472
0.3054.04%
After Hours: Dec 5, 4:01 PM EDT

Eagle Pharmaceuticals (OTC:EGRX) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Eagle Pharmaceuticals (EGRX)?

A

The most recent guidance for Eagle Pharmaceuticals (EGRX) was reported on September 7, 2023 for the full year 2023. The company provided earnings per share guidance in the range of $4.40 to $4.70, compared to the estimated EPS of $4.58. Additionally, Eagle Pharmaceuticals forecasted revenue between $0.00B and $0.00B for the quarter.

Browse guidance and forecast on all stocks.